T. Rowe Price Investment Management
OSCR icon

T. Rowe Price Investment Management’s Oscar Health OSCR Stock Holding History

T. Rowe Price Investment Management’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$372M Buy
13,035,486
+1,390,990
+12% +$29.9M 0.24% 109
2026
Q1 		$134M Buy
11,644,496
+2,426,680
+26% +$34.2M 0.09% 211
2025
Q4 		$132M Buy
9,217,816
+910,320
+11% +$15.7M 0.08% 215
2025
Q3 		$157M Sell
8,307,496
-4,343,766
-34% -$71.6M 0.1% 207
2025
Q2 		$271M Buy
12,651,262
+825,017
+7% +$12.3M 0.17% 142
2025
Q1 		$155M Buy
11,826,245
+467,301
+4% +$6.94M 0.1% 205
2024
Q4 		$153M Sell
11,358,944
-302,122
-3% -$4.86M 0.09% 218
2024
Q3 		$247M Buy
11,661,066
+375,471
+3% +$6.76M 0.15% 161
2024
Q2 		$179M Buy
11,285,595
+2,742,749
+32% +$50.4M 0.11% 194
2024
Q1 		$127M Buy
+8,542,846
New +$117M 0.08% 252

Other funds holding OSCR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Investment Management's OSCR Position: Q2 2026 in Review

T. Rowe Price Investment Management increased its Oscar Health (OSCR) stake by 12% in Q2 2026, buying an estimated $29.9M and bringing the position to 13,035,486 shares worth $372M. The position accounts for 0.24% of the portfolio, ranked #109.

T. Rowe Price Investment Management first reported a position in OSCR in Q1 2024 and has held it in 10 quarters since. 403 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • T. Rowe Price Investment Management held 13,035,486 shares of Oscar Health worth $372M as of Q2 2026.
  • T. Rowe Price Investment Management bought 1,390,990 Oscar Health shares in Q2 2026, an estimated $29.9M.
  • Oscar Health made up 0.24% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #109 holding.
  • T. Rowe Price Investment Management first reported a position in Oscar Health in Q1 2024 and has held it in 10 quarters since.
  • 403 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.